PATENT CLAIM ANALYSIS

Application Number: 16330337
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "465000"]

Abstract:
A pharmaceutical composition including neptinib is provided. The composition includes neptinib or a pharmaceutically acceptable salt thereof, and an excipient at a low risk of compatibleness. Furthermore, the pharmaceutical composition of the present invention may also include pharmaceutically acceptable organic acid or inorganic acid as a stabilizer. The content of impurity A maintains a non-significant increase in the long-term and accelerated stability investigation for the pharmaceutical composition.

Claim (Index 12):
A preparation comprising the pharmaceutical composition of  claim 1 , wherein its dosage form is tablet coated with HPMC film.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 99.0
- Lexical Diversity: 1.52083
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12683696', '14661693', '11811327', '15174467', '13933788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6706606980698864
- 35 USC 102 Novelty (BERT): 0.500836563843109
- Combined Prediction Score: 0.6536782846472087
- Mean Citation Score: 205.00513
- Max Citation Score: 222.64699
- Similarity Product: 156.6364113386321

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test